Home >> Marketplace Directory >> NGS bacterial meningitis test

NGS bacterial meningitis test

image_pdfCreate PDF

February 2019—Viracor Eurofins launched a 16S Next Generation Sequencing Bacterial Meningitis test for use in patients suspected of having bacterial meningitis. Physicians will receive test results for difficult-to-diagnose immunocompromised patients within three business days from specimen receipt.

Viracor Eurofins amplifies the 16S gene using PCR, followed by the use of next-generation sequencing, to identify and report the bacterial pathogen in a patient’s CSF sample. The assay was validated to include the most common bacterial pathogens associated with meningitis: Streptococcus pneumoniae, Neisseria meningitidis, Haemophilus influenzae, Listeria monocytogenes, Streptococcus agalactiae, and Escherichia coli as well as other less common pathogens that may be clinically important in immunocompromised patient populations.

CAP TODAY
X